Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) EBIT Margin (2020 - 2025)

Historic EBIT Margin for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to 8.34%.

  • KORU Medical Systems' EBIT Margin rose 124800.0% to 8.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.28%, marking a year-over-year increase of 117700.0%. This contributed to the annual value of 19.16% for FY2024, which is 168500.0% up from last year.
  • Latest data reveals that KORU Medical Systems reported EBIT Margin of 8.34% as of Q3 2025, which was up 124800.0% from 3.07% recorded in Q2 2025.
  • KORU Medical Systems' 5-year EBIT Margin high stood at 3.07% for Q2 2025, and its period low was 55.2% during Q2 2022.
  • For the 5-year period, KORU Medical Systems' EBIT Margin averaged around 27.61%, with its median value being 24.98% (2021).
  • In the last 5 years, KORU Medical Systems' EBIT Margin crashed by -499600bps in 2021 and then skyrocketed by 323500bps in 2024.
  • Over the past 5 years, KORU Medical Systems' EBIT Margin (Quarter) stood at 32.56% in 2021, then dropped by -5bps to 34.19% in 2022, then grew by 11bps to 30.58% in 2023, then soared by 41bps to 17.98% in 2024, then skyrocketed by 54bps to 8.34% in 2025.
  • Its EBIT Margin was 8.34% in Q3 2025, compared to 3.07% in Q2 2025 and 12.92% in Q1 2025.